Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;37(8):749-755.
doi: 10.14670/HH-18-479. Epub 2022 Jun 7.

PD-L1 positive lympho-epithelial lesions in inflammatory prostate

Dorian Dikov  1   2 , Maria Koleva  3 , Kiril Simitchiev  4 , Marin Baltov  5 , Victoria Sarafian  6
Affiliations

PD-L1 positive lympho-epithelial lesions in inflammatory prostate

Dorian Dikov et al. Histol Histopathol. 2022 Aug.

Abstract

Objectives: Ductal epithelial changes (lympho-epithelial lesions-LEL) in prostatic chronic inflammation (CI) are not well studied so far.

Aim: to investigate LEL immediately adjacent to prostatic CI.

Methods: We studied LEL in 144 prostatic surgical and autopsy specimens in various types of prostatic CI: NIH-category IV prostatitis (histologic prostatitis-HP), nonspecific granulomatous prostatitis (NSGP), and the reactive lymphoid infiltrates in the vicinity of benign prostatic hyperplasia (BPH) and prostate adenocarcinoma (PCa). CI is scored as low and high grade (LG, HG) according to the severity of inflammation.

Results: LEL was identified in all types of prostatic specimens and in all types of prostatic CI: in 70.9% of patients with HP; in 100% of cases with NSGP; in 68.7% and in 80% adjacent to BPH and PCa respectively. Statistical analysis showed a significant correlation of the presence of LEL with HG CI (p<0.001). LEL showed strong membranous PD-L1 expression.

Conclusions: The study presents the first attempt to examine LEL in inflammatory human prostate. PD-L1 positive LEL have no diagnostic organ specificity, although they are a constant histological finding in HG prostatic CI. LEL, inducible after birth by CI, are an integral part of prostate-associated lymphoid tissue (PALT) and of the inflammatory prostatic microenvironment.

PubMed Disclaimer

References

    1. lumenfeld W., Tucci S. and Narayan P. (1992). Incidental lymphocytic prostatitis: selective involvement with non-malignant glands. Am. J. Surg. Pathol. 16, 975-981. - PubMed
    1. Cruickshank A.H. (1965). Benign lymphoepithelial lesion to be distinguished from adenolymphoma. J. Clin. Pathol. 18, 391-400. - PMC - PubMed
    1. Chulkina M., Beswick E.J. and Pinchuk I.V. (2020). Role of PD-L1 in gut mucosa tolerance and chronic inflammation. Int. J. Mol. Sci. 21, 9165. - PMC - PubMed
    1. Delongchamps N.B., de la Roza G., Chandan V., Jones R., Sunheimer R., Threatte G., Jumbelic M. and Haas G.P. (2008). Evaluation of prostatitis in autopsied prostates: is chronic inflammation more associated with BPH or cancer? J. Urol. 179, 1736-1740. - PMC - PubMed
    1. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Gronberg H., Drake CG., Nakai Y., Isaacs W.B. and Nelson W.G. (2007). Inflammation in prostate carcinogenesis. Nat. Rev. Cancer. 7, 256-269. - PMC - PubMed